Hu-mice infected with p12stop HTLV-1 showed disease development with a median survival of 4.3 weeks, whereas only 35% of the HTLV-1-CTCF infected mice developed disease within 12.5 weeks of infection (Fig 1B). Here, CTCF is linked to infection.